XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 848 $ (288)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, depletion, accretion, and amortization 6,985 415
Deferred income taxes (2,460)
Unrealized (gain) loss on commodity derivatives (1,155) 116
Loss (gain) on marketable equity securities 85 (67)
Impairment and loss on real estate held for sale 75 141
Amortization of debt issuance costs 32
Loss on warrant revaluation (2)
Loss on related party debt conversion and settlement of legal costs 76
Stock-based compensation 2,594 310
Right of use asset amortization 140 66
Changes in operating assets and liabilities:    
Oil and natural gas sales receivable (3,587) (570)
Other assets 320 130
Accounts payable and accrued liabilities 5,456 (215)
Accrued compensation and benefits (479) (43)
Payments on operating lease liability (68) (66)
Payments for asset retirement obligations (289) (22)
Net cash provided by (used in) operating activities 8,497 (19)
Cash flows from investing activities:    
Acquisition of proved properties (12,610)
Oil and natural gas capital expenditures (5,369) (1,399)
Property and equipment expenditures (379) (93)
Proceeds from sale of oil and gas properties 1,250 30
Proceeds from sale of real estate 440
Payment received on note receivable 20
Net cash used in investing activities (17,108) (1,002)
Cash flows from financing activities:    
Proceeds from sale of common stock, net of issuance costs 5,283
Borrowings on credit facility 15,200  
Repayment of debt (6,047)  
Payment of fees for credit facility (207)  
Repayments of insurance premium finance note payable (396) (122)
Exercise of warrant 195  
Shares withheld to settle tax withholding obligations for restricted stock awards (307) (39)
Dividend paid (1,156)  
Net cash provided by financing activities 7,282 5,122
Net (decrease) increase in cash and equivalents (1,329) 4,101
Cash and equivalents, beginning of period 4,422 2,854
Cash and equivalents, end of period $ 3,093 $ 6,955